Plain-English translation of NCT03450512 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This is a research study designed to better understand a serious bowel condition called neutropenic enterocolitis that can develop in people with acute myeloid leukemia (AML) when their white blood cell counts drop during chemotherapy. The study uses CT scans to detect this condition early and track how often it happens, hoping that catching it sooner will help doctors prevent serious complications and improve patient outcomes.
This condition causes serious illness and complications in people with AML during treatment, but it's not well understood because doctors don't currently screen for it systematically. By studying it carefully, researchers hope to develop better ways to detect and treat it early.
If you join, you'll receive standard chemotherapy for your AML as planned. During your treatment, if you develop a fever that doesn't improve after 5 days of antibiotics and you have digestive symptoms (like belly pain or diarrhea), you'll have a CT scan to check for the bowel condition being studied. Doctors will also collect information about your symptoms and test results throughout your treatment. The study continues through the end of your intensive chemotherapy courses.
AI-generated summary from trial data · Jun 3, 2026 · Not medical advice
France